Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145943 | SCV000193082 | likely pathogenic | Chondrodysplasia punctata 2 X-linked dominant | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Department Of Translational Genomics |
RCV000171436 | SCV000221634 | likely pathogenic | not provided | criteria provided, single submitter | research | ||
Gene |
RCV000439113 | SCV000517447 | likely benign | not specified | 2015-06-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV000171436 | SCV000885349 | benign | not provided | 2018-06-17 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000171436 | SCV001024322 | likely benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000145943 | SCV001141852 | uncertain significance | Chondrodysplasia punctata 2 X-linked dominant | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003905265 | SCV004724850 | likely benign | EBP-related condition | 2021-04-01 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Diagnostic Genome Analysis, |
RCV000171436 | SCV001800541 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000171436 | SCV001965513 | likely benign | not provided | no assertion criteria provided | clinical testing |